Icturn, a properly-regarded commercial hepatoprotective PLF in Bangladesh, continues to be utilized as an efficient procedure in liver health conditions. Pretreatment with Icturn prevented the increase in liver enzyme parameters and retained them to in close proximity to usual level when administered at 5.2 ml/kg BW/d dose in CCl4-induced hepatoxic https://www.directivepublications.org/annals-of-pharmacology-and-pharmaceutical-sciences/